ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Move To NCI director’s Office gives Greater Visibility To NCI Liaison Office

September 13, 1996

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants

August 14, 1981

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007